• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

AMGEN INC.

Notes

No. Proposition For Against Abstain
1

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Wanda M. Austin

2

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Bradway

3

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Michael V. Drake

4

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Brian J. Druker

5

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Eckert

6

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Greg C. Garland

7

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Charles M. Holley, Jr.

8

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. S. Omar Ishrak

9

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Tyler Jacks

10

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Mary E. Klotman

11

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Ellen J. Kullman

12

Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Amy E. Miles

13

Advisory vote to approve our executive compensation.

14

To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026.

15

Stockholder proposal to require an independent board chairman.